Pharyngeal Exercise (Plus Protein)
PE(PP)
A Single-center Randomized Clinical Trial to Test the Efficacy of Pharyngeal Swallowing Exercises (With or Without Protein Supplementation) to Build Pharyngeal Muscular Reserve in Pre-frail Older Adults
1 other identifier
interventional
120
1 country
2
Brief Summary
The swallowing muscles are prone to decreased strength and function as part of the natural aging process which can lead to difficulty swallowing, malnutrition, and frailty. Exercise and nutrition are powerful stimulators of muscular change. The proposed research will investigate the effectiveness of a 12-week proactive regimen of swallowing exercises (with or without daily protein supplement drinks) to improve the composition, force, and physiology of the swallowing muscles and explore the relationship to overall health and physical function in 80 community-dwelling older adults. Each participant will serve as their own control for 12 weeks before being randomized to complete swallowing exercises alone or swallowing exercises with protein drinks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedStudy Start
First participant enrolled
May 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
August 5, 2025
August 1, 2025
4.3 years
July 19, 2023
August 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Change in Thickness of the Superior Pharyngeal Constrictor Muscle
Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the superior pharyngeal constrictor muscle.
Baseline, Week 13
Change in Thickness of the Superior Pharyngeal Constrictor Muscle
Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the superior pharyngeal constrictor muscle.
Baseline, Week 28
Change in Thickness of the Middle Pharyngeal Constrictor Muscle
Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the middle pharyngeal constrictor muscle.
Baseline, Week 13
Change in Thickness of the Middle Pharyngeal Constrictor Muscle
Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the middle pharyngeal constrictor muscle.
Baseline, Week 28
Change in Thickness of the Inferior Pharyngeal Constrictor Muscle
Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the inferior pharyngeal constrictor muscle.
Baseline, Week 13
Change in Thickness of the Inferior Pharyngeal Constrictor Muscle
Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the inferior pharyngeal constrictor muscle.
Baseline, Week 28
Change in Maximum Pharyngeal Constriction During Swallowing
Maximum pharyngeal constriction area (normalized to spine length) will be captured at the height of the swallow on videofluoroscopy.
Baseline, Week 13
Change in Maximum Pharyngeal Constriction During Swallowing
Maximum pharyngeal constriction area (normalized to spine length) will be captured at the height of the swallow on videofluoroscopy.
Baseline, Week 28
Secondary Outcomes (6)
Change in Short Physical Performance Battery (SPPB) Scores
Baseline, Week 13
Change in Short Physical Performance Battery (SPPB) Scores
Baseline, Week 28
Change in Fat-Free Muscle Index
Baseline, Week 13
Change in Fat-Free Muscle Index
Baseline, Week 28
Change in Pre-Albumin Levels
Baseline, Week 13
- +1 more secondary outcomes
Study Arms (2)
Control, then Swallowing Exercises + Protein
EXPERIMENTALParticipants randomized to 12 weeks of swallowing exercises with protein supplementation, after completing an initial 12-week period of "usual activity."
Control, then Swallowing Exercises
ACTIVE COMPARATORParticipants randomized to 12 weeks of swallowing exercises without protein supplementation, after completing an initial 12-week period of "usual activity."
Interventions
12-weeks of proactive pharyngeal swallowing exercises conducted 5 times per week. The exercise program will include the following four exercises: effortful saliva swallows, tongue-hold swallows, effortful pitch glides and posterior lingual resistance. Each exercise set will include 10 repetitions of each exercise (40 reps per set). The number of sets will be gradually increased as tolerance builds.
12-week supply of the commercially-available Premier Protein Clear ® High Protein (20 grams of protein and 90 calories per 16.9 oz. drink). Participants will be asked to consume one drink per day for the 12-week intervention period.
Participants will be scanned using a 3T MRI scanner and a 16-channel phased array neck coil.
Eligibility Criteria
You may qualify if:
- Participants must be 65 years of age or older.
- Participants must score a 1 or 2 on the FRAIL scale OR a 4 or greater on the Strength, Assistance in Walking, Rise from a Chair, Climb Stairs and Falls (SARC-F) Questionnaire.
- Participants must score 26 or greater on the Montreal Cognitive Assessment (MoCA).
- Willingness to participate in the study procedures.
You may not qualify if:
- Known structural or neurological causes of dysphagia.
- Cannot consume high levels of protein (Chronic Kidney Disease Stage 3 or higher).
- Contraindications to 3T whole body MRI scanners (e.g., pacemaker, cerebral aneurysm clip, cochlear implant, presence of shrapnel in strategic locations, metal in the eye, claustrophobia, or other problems).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NYU Langone Healthlead
- National Institute on Aging (NIA)collaborator
Study Sites (2)
NYU Steinhardt School of Education
New York, New York, 10003, United States
NYU Langone Health
New York, New York, 10017, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Sonja Molfenter
NYU Langone Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The PI, outcome assessors, and individuals conducting data analyses will be blinded to randomization. The treating clinicians and participants will be aware of their study group given that they will be provided with either water or protein drinks.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2023
First Posted
July 27, 2023
Study Start
May 22, 2024
Primary Completion (Estimated)
August 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
August 5, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to smm16@nyu.edu. To gain access, data requestors will need to sign a data access agreement.
The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: smm16@nyu.edu. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.